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Abstract
Hypertension is a major problem in the United States. It is critical to identify effective strategies
to treat and manage hypertension. An experimental design was utilized to determine the
effectiveness of home-based blood pressure monitoring (HBPM) in the management of prehypertension, newly diagnosed, or uncontrolled hypertension. A randomized convenience sample
of 20 adults was recruited into a control (n=9) and experimental (n=11) group. The translational
care project was conducted over 60 days where participants measured their blood pressures as
instructed for the intervention and control groups. An independent t-test was conducted to
analyze the effectiveness of HBPM on the participants’ blood pressure, blood pressure
knowledge, self-care, and medication adherence utilizing subsequent scales. There was a
statistically insignificant increase in systolic blood pressure, but a statistically significant
increase in diastolic blood pressure between the experimental and control groups at 60 days.
There was no statistical significance in the improvement of HBPM adherence, knowledge, selfcare, or medication adherence between the two groups at 60 days. While there is limited
statistical support for this translational research project, other resources support HBPM as an
innovative program that has the potential to provide healthcare providers an avenue for more
timely, effective, and individualized patient care. Literature demonstrates that improved blood
pressure control has the potential to decrease the prevalence of co-morbid conditions and
decrease health care costs. With an increase in successful studies legislation could be challenged
to increase coverage and reimbursement cost for blood pressure monitors and more HBPM
programs in practice. Continued research related to HBPM and patient adherence is necessary to
improve patient access to affordable care and overall self-care outcomes.
Keywords: hypertension, home, blood pressure, monitoring, self-care
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Implementing a Home-Based Blood pressure Monitoring Program
To Improve Hypertension Management
Chapter I
Introduction
According to the National Health and Nutrition Examination Survey (NHANES) (20112012), approximately 70 million people in the United States (US) have high blood pressure,
clinically known as hypertension (Nwankwo, 2014). Complications as a result of hypertension
and rising health care costs make this an important issue to address. Best practices demonstrate
that daily blood pressure monitoring in the home setting, also known as Home-Based Blood
Pressure Monitoring (HBPM), increases patient awareness of the disease process and allows
patients to monitor their blood pressure in their natural setting (Parati et al., 2010). Results from
home blood pressure monitoring allows for providers to analyze home data trends and provide
appropriate feedback. The purpose of this translational research project is to determine the
effectiveness of home-based blood pressure monitoring in the management of those diagnosed
with pre-hypertension, newly diagnosed, or uncontrolled hypertension.
Problem
Currently, hypertension diagnosis and management is based on several blood pressure
readings conducted in various clinical settings at random times of the day. However, a single
blood pressure reading in the conventional office or emergency room setting does not reflect
whether the patient is hypertensive or if hypertension is being managed properly. High blood
pressures in the office setting could be related to stress and the white-coat phenomenon. Whitecoat refers to a false elevation in blood pressure in the provider’s office, hence white-coat (Parati
et al., 2010). Daily blood pressure monitoring in the home setting increases patient awareness of
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disease process, allows patients to monitor their blood pressure in their normal setting, helps
detect white-coat or masked hypertension, and provides several measurements where blood
pressure trends can be evaluated (Parati et al., 2010). Results from daily monitoring allows for
providers to analyze home data trends and provide appropriate feedback. Therefore,
implementation of a home-based blood pressure monitoring program has the opportunity to
improve hypertension management and encourage self-management practices among
hypertensive patients.
Background
The American Heart Association (AHA, 2016a) describes blood pressure as the force of
the blood within the heart, which is measured by a fraction of two numbers. The systolic blood
pressure (numerator) measures the pressure in the arteries when the heart contracts and the
diastolic blood pressure (denominator) measure the relaxation phase of the heart when it refills
with blood (AHA, 2016a). Blood pressure results are usually obtained using a
sphygmomanometer in the upper arm above the elbow. Normal blood pressure is considered
anything less than 120/80 and anything greater than this is considered pre-hypertensive or
hypertensive. Pre-hypertension constitutes an increased blood pressure level between 121/81 and
139/89 where providers may consider further evaluation. Hypertension is an elevated blood
pressure, greater than 140/90, where the force of blood pushing against the vessels of the heart is
too high and requires prompt evaluation and treatment (AHA, 2016b).
With the large prevalence of Americans having hypertension, the US experiences an
health care spending cost of over $46 billion dollars annually for the management of
hypertension and associated comorbidities (Nwankwo, 2014). According to the American Heart
Association (AHA), uncontrolled hypertension results in end-organ damage, which includes
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heart disease, heart failure, stroke, and renal death (AHA, 2016b). In the US, hypertension and
diabetes are the leading causes of kidney disease resulting in end-stage renal disease (ESRD) and
death (CDC, 2014). In 2012, over $29 billion of the Medicare budget was used in the
management of kidney disease and failure (CDC, 2015). Among African Americans, one of the
leading causes of Chronic Kidney Disease (CKD) is uncontrolled hypertension with a prevalence
rate of approximately 45% among men and women (Nwankwo, 2014). African Americans also
have a 2-fold higher incidence of uncontrolled hypertension and an eight-time higher risk of
stroke (Piper et al., 2015).
The CDC developed quality initiatives for the prevention, treatment and control of
hypertension (CDC, 2015). With the substantial evidence of the prevalence of hypertension and
its associated costs for comorbid conditions, it is imperative to implement evidence-based
research strategies for improving hypertension management. A literature review demonstrated
the potential for Home-based blood pressure monitoring (HBPM) to improve the care of those
with hypertension. HBPM is the act of taking an individual’s blood pressure in the comforts of
the patients’ home and recording results for later evaluation by the patients’ provider. The
objective of this translational research project was to disseminate evidence-based care practices
for blood pressure management through implementing home-based blood pressure monitoring
into the health care setting.
Terms and Definitions
Ambulatory blood pressure Monitoring (ABPM) is a diagnostic procedure where an
automatic cuff is given to the patient from an outpatient lab source and measurements are taken
every 15-20 minutes during the day and 20-30 minutes at night through a 24-hour period
(Cohen, Huan, and Townsend, 2014).
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Chronic Kidney or Renal Disease is a condition involving the decline of the kidney
function, which normally cleans and filters the blood (CDC, 2014). In relation to hypertension it
is important for blood pressures to remain stable to prevent further kidney damage.
Diabetes Mellitus is a condition where the blood’s sugar levels remain elevated for long
periods of times (CDC, 2011). Due to the ability of this condition to cause further damage to
multiple organs including the heart, it is important that blood pressures remain stable.
Electronic blood pressure Monitoring (EBPM) is similar to HBPM, but includes
transmitting the blood pressure results electronically to the health care provider via email or into
the patient’s electronic medical record (EMR) (Cohen, Huan, and Townsend, 2014).
Home-Based Blood pressure Monitoring (HBPM) is defined as the act of taking an
individual’s blood pressure in the patient’s home twice daily (Cohen, Huan, and Townsend,
2014).
Office blood pressure Monitoring (OBPM) occurs in the office setting where
measurements are taken at the patients’ appointment for objective vital signs (Cohen, Huan, and
Townsend, 2014).
Purpose
The purpose of the translational research project was to determine the effectiveness of
home-based blood pressure monitoring in the management of pre-hypertension, newly
diagnosed, or uncontrolled hypertension. Since uncontrolled hypertension is one of the leading
causes of end-organ damage, which includes heart disease, stroke, and renal death predominantly
in African Americans, the objective was to disseminate evidence-based care practices for blood
pressure management into the health care setting. The primary investigator (PI) developed a
home-based blood pressure monitoring program utilizing an educational program and the Omron
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sphygmomanometer, a blood pressure monitoring device. The Omron blood pressure monitor
records and stores blood pressure results and downloads results to an Omron Wellness
application ("10 Series Upper Arm Blood Pressure Monitor," 2016). Though this mobile
application blood pressure results are transmitted to the health care provider via a secure email.
The goal was to provide an easily adaptable implementation process for the home-based
monitoring system in practice and to improve monitoring compliance and blood pressure results.
This innovative technology has the potential to help health care providers deliver individualized
patient care based on accurately reported blood pressure results. Improved blood pressure control
has the potential to decrease complications of uncontrolled blood pressure and decrease health
care costs.
Aims and Clinical Questions
There were three main aims for this translational research project:
1. To reduce resting blood pressure to less than 140/90, in Diabetics (individuals with
elevated blood sugars) and Renal disease (individuals with a decline kidney in kidney
function) 130/80, or demonstrate a 5% reduction in blood pressure among men and
women with primary hypertension.
a. In adults’ age 18-60 years old with primary hypertension, what is the effect of
a home-based blood pressure monitoring program compared to conventional
outpatient blood pressure monitoring in the health care setting within 60 days?
2. To increase adherence to home blood pressure monitoring among men and women
with primary hypertension.
a. Does HBPM in patients with primary hypertension increase adherence to
home blood pressure monitoring?
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3. To increase adherence to hypertension lifestyle changes.
a. Does HBPM in patients with primary hypertension increase adherence to selfcare lifestyle changes?
4. To increase adherence to hypertension medication therapy.
a. Does HBPM in patients with primary hypertension increase adherence to
medication compliance?
Opportunities and Challenges
Since uncontrolled hypertension is one of the leading causes of CKD in African
Americans, the objective is to disseminate evidence-based care practices for blood pressure
management into the primary care setting. Research demonstrates that home-based blood
pressure monitoring can increase the diagnosis and management of hypertension as opposed to
office blood pressure monitoring (Crabtree & Stuart-Shor, 2014). This translational research
project provides a roadmap to implementing HBPM into practice. The PI developed a homebased blood pressure monitoring program that facilitated a step-wise approach to tackling
hypertension monitoring and management. The future goal is to have an interface system for
every primary care or hypertension clinic. This would allow remote management of hypertension
and increase productivity for other acute or chronic visits. HBPM has the potential to minimize
follow-up visits related to blood pressure rechecks and allows the patient to conserve resources
related to transportation or time off work. This innovative technology has the potential to health
care providers deliver individualized patient care based on accurately reported blood pressure
results (Young et al., 2015). Improved blood pressure control potentially decreases associated
co-morbid conditions and thereby decreases health care expenditures and expenses (CDC, 2015).
The primary stakeholders for this project were the patients and patients’ families. Other
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stakeholders include health care providers, nurses, and medical assistants. There were no major
financial burdens to incur with the implementation of HBPM to the health care clinics or
patients. The PI enlisted funding through a “Go Fund Me” account, which solicited donations.
Funding from the “Go Fund Me”, Carolyn M. Maynard Nursing Scholarship fund and Marjorie
G. Prentice Graduate Research Scholarship provided blood pressure monitors to participants and
covered the cost related to educational materials. However, the cost of monitors may become a
challenge for practices without grant or governmental assistance. Training and education on the
proper procedure for taking the blood pressure and the Omron Wellness application for the staff
and patients was necessary. The PI conducted educational sessions demonstrating the appropriate
frequency of blood pressure monitoring, proper body mechanics when taking blood pressure, and
documentation with the Omron Wellness application. This could also commence a challenge, for
this would require additional staffing or time dedicated to patient education and staff training that
would deduct from regularly scheduled patient care. Most importantly, the patients must be fully
invested in their own health and assume responsibility for adhering to the treatment plan.
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Chapter II
Review of Literature and Synthesis
This chapter will review current literature regarding HBPM in relation to the
management of hypertension. The chapter discusses the search criteria utilized to obtain
literature and defines terms related to HBPM and blood pressure management. Lastly, a
synthesis of the major themes identified and critical analysis of literature is detailed in this
section.
Search for Evidence
The investigation consisted of a search of research-based articles in CINHAL,
MEDLINE, MEDLINE Plus Text, and PubMed published in 2010 or later. The search terms
used were “home blood pressure monitoring” AND “hypertension” AND “African Americans”
OR “Chronic Kidney Disease”. Some articles revealed alternate forms of HBPM. Therefore,
alternate terms were searched including “ambulatory blood pressure monitoring,” “home-based
blood pressure monitoring,” “self-blood pressure monitoring,” “office blood pressure
monitoring,” and “electronic blood pressure monitoring.” Articles were eliminated based on the
amount of relevance to HBPM in the management of hypertension and evidence strength. 23
articles were reviewed and 12 were selected for the inclusion in this synthesis of research.
Summary of Evidence
The literature reviewed consisted of literature reviews (4), randomized controlled trials
(4), and case/cohort studies (3) that supported the use of either HBPM or ambulatory blood
pressure monitoring (ABPM). The synthesis of literature revealed three major themes: 1) HBPM
improves blood pressure control, 2) HBPM provides prognostic and diagnostic value of high
blood pressure and decreases the progression of co-morbid conditions, including Chronic Kidney
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Disease (CKD), 3) SMBP or HBPM provided an equivocal measurement of blood pressure as
compared to ABPM. The following provides a summary of the research evidence discovered in
the literature review in support of the implementation of the translational research project.
The main theme discovered was that HBPM demonstrated a significant improvement in
blood pressure management. McManus et al. (2010) reports a prospective-randomized control
trial of 480 Caucasian patients that compared HBPM to traditional office based care. Results
showed an average decrease of 30.5 mmHg in systolic blood pressure, which was statistically
significant (p=0.002) (McManus et al., 2010). The same author conducted a similar randomized
clinical trial to determine the effect of self-measured blood pressure monitoring (SMBP); results
showed a 12-point reduction in systolic blood pressure after 12 months (McManus et al., 2014).
The randomized control trial by Margolis et al. (2012) was a HBPM program that involved a
pharmacist dosing and titrating antihypertensive medications based on blood pressure results
received from a blood pressure telemonitoring system. In 228 patients from the telemonitoring
intervention, an average reduction of 18 mmHg was noted in the systolic blood pressure
(Margolis et al., 2012). Crabtree and Stuart-Shor (2014) developed an HBPM program in a
community health center; results showed that among 50 patients, 60% experienced blood
pressure improvement and 84% stated the program helped increase their knowledge and
understanding of blood pressure management. In a case study of 46 CKD patients, White (2009)
focused on increasing patient involvement in a HBPM program. The case study showed a 50%
improvement in blood pressure management among CKD patients with hypertension (White,
2009). A literature review of 52 prospective comparative studies on SMBP monitoring in adults
with hypertension by Uhlig, Patel, Ip, Kitsios, and Balk (2013) provided supportive evidence of
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the use of SMBP alone or in combination with medication regimen improved blood pressure
control compared to office setting monitoring.
The second theme identified was that ABPM and HBPM alike provided prognostic and
diagnostic value in high blood pressure. Researchers were able to diagnose masked or white-coat
hypertension, as well as predict end-organ damage from uncontrolled hypertension with HBPM.
Another prospective cohort studied the prognostic ability of ABPM in 436 CKD patients
(Minutolo et al., 2011). After approximately four years of tracking and trending this group of
patients, 86 of the patients progressed to ESRD (20%), 63 experienced non-fatal cardiovascular
events (14%) and 52 succumbed to cardiovascular death (12%) (Minutolo et al., 2011). This
study demonstrated that nighttime blood pressure with ABPM proved to be an accurate
prediction of renal and cardiovascular risk (Minutolo et al., 2011). A similar literature review by
Cohen, Huan, and Townsend (2014) showed that HBPM and ABPM were useful instruments in
the diagnosis of hypertension. Stergiou, Kollias, Zeniodi, Karpettas, and Ntineri (2014)
conducted a literature review revealing the advantages and limitations of HBPM in clinical
practice; the evidence exhibited that HBPM has prognostic and diagnostic ability, and improved
medication adherence. Piper et al (2015) also conducted a literature review that examined the
benefits of ABPM for diagnostic and predictive value; a review of 27 articles showed strong
evidence that ABPM is more accurate in the diagnosis of hypertension.
Lastly, evidence demonstrated that HBPM provided an equivocal measurement of blood
pressure as compared to ABPM, a more expensive diagnostic monitoring technique (McGowan
& Padfield, 2010). McGowan and Padfield (2010) conducted a comparative study among 87
participants whom had recently undergone ABPM. The researchers provided blood pressure
monitors and education to the individuals and compared SMBP to ABPM. Results demonstrated

HYPERTENSION MANAGEMENT WITH HBPM

11

that there was no difference in blood pressure results obtained via ABPM versus SMBP
(McGowan & Padfield, 2010). Stergiou, et al. (2014) not only provided diagnostic value of
HBPM as previously stated, but research also exhibited that HBPM is reflective and consistent
with ABPM. This summary of evidence provides a foreground in developing a framework to
disseminate a home-based blood pressure monitoring program in the care of patients with prehypertension, uncontrolled hypertension or newly diagnosed hypertension.
Summary of Expert Evidence
The U.S. Preventive Services Task Force (USPSTF, 2016) published the final
recommendation for the utilization of ambulatory blood pressure monitoring (ABPM) in the
screening and diagnosis of hypertension, titled “Final Recommendation Statement: High Blood
Pressure in Adults: Screening”. The study investigated how well home and ambulatory blood
pressure monitoring methods predict cardiovascular events compared with clinic-based blood
pressure measurement methods. The USPTF (2016) recommends that ambulatory blood pressure
monitoring and home blood pressure monitoring be utilized prior to diagnosing hypertension and
beginning treatment. The USPTF (2016) also states that “good-quality” evidence demonstrates
that HBPM is equally as effective as ABPM in the diagnosis and management of hypertension.
Critical Analysis of Current Evidence
The literature reviewed for the project consisted of literature reviews (Cohen et al., 2014;
Parati et al., 2010; Piper et al., 2015; Uhlig et al., 2013), randomized controlled trials (Margolis
et al., 2012; McManus et al., 2010; McManus et al., 2014; Stergiou, et al., 2014), and cohort
studies (Crabtree & Stuart-Shor, 2014; McGowan & Padfield, 2010; Minutolo et al., 2011;
White, 2009) that supported the use of either HBPM or ambulatory blood pressure monitoring
(ABPM). Literature reviews and randomized control trials are considered to be the highest
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quality of research and made up a majority of this literature review. A critical analysis of the
research literature was conducted utilizing Melnyk and Fineout-Overholt (2011) critical appraisal
of quantitative research to assess validity, reliability and applicability.
Literature Reviews
A narrative review of blood pressure monitoring in CKD patients conducted by Cohen et
al. (2014) discusses the results and findings of several research articles. The review describes
only a few of the studies locations, sample sizes, length of follow-up and outcomes. The results
discuss the benefit of HBPM in the use of blood pressure management in patients with CKD and
predicting end-organ damage. However, this particular literature review was not systematic or
methodological in its approach, and lacks an intervention effect or any statistical significance.
Cohen et al. (2014) remains applicable to the translational research project at hand by reviewing
recent literature that provides guidance on proper blood pressure monitors for HBPM, discussing
the importance of ruling out white-coat hypertension and masked hypertension to diagnose true
high blood pressure, and providing a foreground for interfacing HBPM into electronic health
records.
Parati et al. (2010) another narrative review provides a summary of guidelines necessary
for HBPM. While this literature review is not methodological in manner, it does provide
supportive national guidelines for the implementation of HBPM into practice. A large
component of applicability resides in this review, for it provides information on the advantages
and shortcomings to HBPM, validated blood pressure monitors, optimal monitoring schedules,
HBPM analysis techniques, and indications for HBPM (Parati et al., 2010). While Parati et al.
(2010) provides a strong basis of clinical guideline support, it was important to note that there
was some conflict of interest with the authors’ relationships with some medical equipment
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vendors.
Piper et al. (2014) established a literature review of 27 research articles to demonstrate
that elevated OBPM should be confirmed by ABPM to avoid over or under diagnosis of
hypertension and improve the diagnostic accuracy of office blood pressure measurement for
screening. This literature review was systematic and methodological in nature by detailing the
populations, sample sizes, and outcomes. Piper et al. (2014) identified and incorporated solely
randomized control trials and graded the literature based on quality. The author also summarized
the review in table format that made it particularly simple to evaluate the hazard ratios and
positive predictive values of the literature review with the displayed treatment effects and 95%
confidence intervals (CI). With HBPM being a more cost-effective way of blood pressure
monitoring outside the office similar to ABPM, this review provides applicability to the
translational research project in supporting HBPM for the diagnosis and treatment of
hypertension.
A systematic review and meta-analysis was conducted by Uhlig et al. (2013) to describe
the efficacy of self-measured blood pressure monitoring (SMBP), also known as HBPM. As
given its subtitle, the literature review was both systematic and methodological in the processes
of data search, extraction and synthesis or research as instituted by the Agency for Healthcare
Research and Quality (AHRQ). The author only sequestered randomized control trials (RCTs)
and provided each published work’s locations, sample sizes, interventions and outcomes. The
literature review synthesized the results of 52 studies detailing the relative risk (RR) and
statistical significance of each study (Uhlig et al., 2013). Uhlig’s et al. (2013) systematic review
and meta-analysis provided significant support for the translational research project in that the
review corresponded SMBP to notably improve blood pressure management over a six-month
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period, especially in the presence of clinical support agents.
Randomized Control Trials
Margolis et al. (2013) is a RCT demonstrating that home-based blood pressure
telemonitoring and pharmacist-led antihypertensive management, improved blood pressure
(SBP) over a 12 month period compared to OBPM and management. The study consisted of the
random assignment of 450 participants into a treatment intervention and control group with
explicit inclusion and exclusion criteria; however, the facilitators and stakeholders were not blind
to the group assignments. Statistical methods were utilized to obtain an effect size for the
prospective sample and authors increased participant recruitment by the calculated odds of
patients completing the study over the predetermined length of time. The interventions utilized
validated blood pressure telemonitors and a one-on-one meeting with a Pharm-D (Margolis et al.,
2013). The study demonstrated an average difference in SBP and DBP of -10.7 mmHg and -6
mmHg at six months from the experimental group to the control group with a CI of 95% (-14.3 -7.3; -8.6 - -3.4) (Margolis et al., 2013). The results of this study are clinically relevant and
imperative to the translational research project of HBPM in hypertension management.
Both McManus et al. (2010) and McManus et al. (2014) are un-blinded RCTs that
measure the effectiveness of SMBP and self-titration of antihypertensive therapy versus usual
care. McManus et al. (2010) simply studied SMBP among primary care practices (n= 480) and
McManus et al. (2014) studied the intervention among those with increased cardiovascular risks
(n=522). Despite the fact that neither studies provided effect size data, both studies’ participants
were recruited and randomly assigned to the treatment and control group with reasons given for
those subjects who did not complete the study in a flow-chart figured in each manuscript. The
intervention groups received blood pressure monitors that were verified and reliable and
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developed self-titration algorithms with their nationally certified primary care providers
(McManus et al., 2010; McManus et al., 2014). In the initial McManus et al. (2010) study there
was a -12.9 mmHg (95% CI 10.4-15.5) decrease in SBP among the experimental group versus
the control groups -9.2 mmHg (95% CI 6.7-11.8). In the study involving at-risk cardiovascular
participants, SBP/DBP was -9.2 mmHg/-3.4 mmHg lower in the intervention group versus the
control group respectively (95% CI 5.7-12.7)/(95% CI 1.8-5.0) (McManus et al., 2014). The
findings of these studies help support the importance of instituting HBPM into practice.
The last RCT was conducted in a hospital outpatient clinic to compare HBPM to ABPM
management (Stergiou, et al., 2014). Participants were blindly randomized into a treatment and
control group based on a statistically identified effect size of 122 participants (Stergiou, et al.,
2014). One strength of the study is the strategic placement of a flow diagram outlining the
recruitment phase of participants and those whom withdrawn from the study, which supports the
use of a flow diagram for this translational research project. The use of this flow diagram
motivated the researcher to construct a similar diagram for this translational research project. The
treatment group received home blood pressure monitors and antihypertensive medications were
titrated based on HBPM results, while the control group utilized either OBPM or ABPM and had
medications titrated based on the clinic or ABPM results (Stergiou, et al., 2014). End-organ
diagnostic testing and blood pressure results were assessed pre and post-intervention to
determine the reliability of HBPM versus ABPM. Stergiou, et al. (2014) provides a visual of the
relationships between the various treatment methods with elements describing the standard error
and confidence intervals. The study demonstrated that HBPM is comparable to ABPM and clinic
management showing no statistical difference between treatments.
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Cohort Studies
Crabtree and Stuart-Shor (2014) is a cohort study to implement HBPM into practice at a
health care facility. Participants were recruited from a single primary care office whom were
diagnosed with a high blood pressure of >140/90 mmHg. Participants were given validated blood
pressure monitors and education on proper blood pressure monitoring and treatment. Crabtree
and Stuart-Shor (2014) indicated a 60% improvement in blood pressure control (BP<130/80), of
which, 84% of patients felt that the HBPM program helped them understand and manage their
blood pressure, enhanced their doctor visits, and added value to their care. Although blood
pressure management improved with HBPM, there was no magnitude of relationship indicators,
p-values or CIs documented in the results. However, there was a strong applicability and
correlation to the presented translational research project in that the study demonstrates Homebased blood pressure monitoring is valuable in the improvement of hypertension knowledge and
disease management adherence among patients.
McGowan and Padfield (2010) conducted a comparative cohort study among 87
participants whom had recently undergone ABPM. The researchers provided validated blood
pressure monitors and education to the individuals and compared SMBP to ABPM. Results
demonstrated that there was no difference in blood pressure results obtained via ABPM versus
SMBP (McGowan & Padfield, 2010). HBPM matched ABPM results in 87% of the individuals.
Statistical analysis demonstrated a correlation and repeatability coefficient of 0.72 (CI 95%,
0.57-0.82) and 5.2 (CI 95%, 4.1-6.2) respectively for SBP (McGowan & Padfield, 2010). For the
DBP the correlation and repeatability coefficient was 0.89 (CI 95%, 4.1-6.2) and 5 (CI 95%, 4.16.2) respectively (McGowan & Padfield, 2010). Subjectivity of the study was limited, however,
no adjustments were made to rule out confounding variables. The applicability of the study in
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HBPM provides reassurance that HBPM can be substituted for ABPM in the clinical setting and
provides accurate results in the care of hypertensive patients.
Specifically in chronic kidney disease, Minutolo et al. (2011) a cohort study, determined
that nighttime ABPM demonstrated precise prediction of renal and cardiovascular risk (n=436).
ABPM was compared to OBPM for predicting the time to end-stage renal death or
cardiovascular complications. Elevated nighttime blood pressure (>137 mmHg SBP) during
ABPM is associated with increased risk of end stage organ death unlike OBPM (Minutolo et al.,
2011). The magnitude of relationship indicators, p-values and CIs are documented in the results
providing reliability to the results. With ABMP being proven to be comparable to HBPM,
HBPM holds similar predictive and prognostic value. While the purpose of the translational
research project is to demonstrate that HBPM improves the management of hypertension, the
applicability in this study lies in the support of HBPM and its role in preventing the progression
of chronic diseases.
White (2009), cohort study conducted at a nephrology practice, recruited 46 CKD
patients with hypertension to perform HBPM. Participants were selected by the clinical staff and
provided with validated blood pressure monitors. Participants submitted HBPM results on a
monthly basis and results demonstrated approximately a 50% improvement in hypertension over
a six-month period. There were subjective statements by the researcher noted in the study report
that could introduce bias to the results. The data analysis did not adjust for risk factors or
confounding variables such as race, age, and gender. Unfortunately, the White (2009) study is
statistically frail with insufficient statistical data and data analysis to support the study of HBPM.
Yet, the results of the study help provide important educational and implementation techniques
for the HBPM translational research project.
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Limitations of Current Evidence
This literature synthesis provides an abundance of research on the topic of HBPM and
has supported the use of various types of self-monitoring techniques for the diagnosis,
management and prognosis of blood pressure control (Cohen et al., 2014; Crabtree & Stuart,
2014; McManus et al., 2014; McManus et al., 2010; Piper et al., 2015; Minutolo et al., 2011;
Margolis et al., 2012; Stergiou et al., 2014; Uhlig et al., 2013; White, 2009). Palatini and Frick
(2012) discuss limitations to the implementation of HBPM into practice to include lack of
methodological implementation, utilization of invalidated blood pressure monitoring equipment,
result inaccuracy related to misreporting, and inadequate staff and patient education. The gap in
the literature was identified with only a few studies having been conducted on the use of HBPM
with the influence of hypertension education on the improvement of hypertension management
and medication adherence.
While national organizations such as the CDC (2015) and USPSTF (2016) support and
provide guidance for the use of HBPM or SBPM alike, there is limited research that
demonstrates that HBPM is effective and worth the efforts of instituting into practice. Some
literature lacks critical quantitative evidence and strength. Of the literature reviewed, common
research limitations were related to the introduction of bias with un-blinded RCTs, inadequate
participant recruitment and under-represented patient samples. Other limitations discovered in
the literature review included: lack of evaluation of confounding variables, inconsistent medical
management and treatment of hypertension, limited study length and follow-up, research
generalizability and reproducibility in multiple settings, and no cost analyses were conducted.
The translational research project addressed several of these factors in effectively implementing
HBPM into practice.
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Strengths of Current Evidence
All the studies examined in this literature review were applicable to the study of HBPM
in the management or improvement of hypertension. A majority of the studies discovered in the
appraisal of literature were systematic reviews or randomized control trials, which are
methodologies that more accurately exemplify the entire population. Several studies like
McManus et al. (2010) and McManus et al. (2014) contained large sample sizes with statistically
supportive results demonstrating that HBPM is effective in blood pressure control and decreases
the risk of end-organ damage. Several studies also provided evidence demonstrating that HBPM
is a more cost effective and reliable substitution for OBPM and ABPM (McGowan & Padfield,
2010; Minutolo et al., 2011; Piper et al., 2015; Stergiou, et al., 2014). Other research studies
provide statistically significant evidence representing that HBPM provides prognostic and
diagnostic value in high blood pressure (Cohen et al., 2014; McManus et al., 2010; McManus et
al., 2014; Minutolo et al., 2011; Piper et al., 2015; Stergiou, et al., 2014). The synthesis of
research provides a framework of support implicating HBPM as a potential factor in the
management of hypertension.
Apply the Evidence
Given the prevalence of cardiovascular disease, kidney disease, and increased health care
costs; it is beneficial to explore HBPM use in the primary care setting where the initial diagnosis
and management of hypertension most often occurs. Utilization of HBPM should be initiated in
the primary care setting to screen, diagnose and manage hypertension on a continuous basis.
Evidence demonstrates that it is imperative to create and apply a methodological approach to
HBPM as to successfully implement in practice. An important step in the methodology is to
ensure patient and staff are properly educated in accurate HBPM procedures. Another important

HYPERTENSION MANAGEMENT WITH HBPM

20

concept in HBPM is the need of an interface or software system similar to the pharmacist-led
study due to the fact that electronic results improve evaluation, accuracy and efficiency of blood
pressure outcomes (Margolis et al., 2013). Further investigation is necessary to determine a
systematic way to effectively implement HBPM into practice.
Theoretical Framework
Translational/Change Theory
“Translating Evidence into Practice: A model of large-scale knowledge translation” by
Pronovost, Berenholtz, and Needham (2008) introduces a model that enables evidence-based
research to be implemented into practice. This theory provides an organized way to implement
home-based blood pressure monitoring for patients with hypertension. The Translating Evidence
into Practice theory is aimed at large-scale research projects and includes four phases:
summarize evidence for improving a specific outcome, identify local barriers of implementation,
identify outcomes of the implementation and performance measures, and finally ensure all
patients reliably receive the intervention (Dudley-Brown, White, & Ebooks, 2012). The change
theory orchestrates the synthesis of research to translate HBPM into practice. The plan is to
utilize evidence-based practice to engage and educate staff on the importance of monitoring
blood pressure outside the primary care clinic on a consistent basis. The PI will implement a
program that records electronic home blood pressure readings and facilitate the electronic
submission of those results. To evaluate the study, a baseline comparison of blood pressures
prior to the intervention and blood pressures post intervention over an eight-week period will be
conducted.
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Hill-Levine Conceptual Model
According to Young et al. (2015), medication non-adherence (70%) was the most
common cause of uncontrolled hypertension in low income African Americans. According to the
survey, causes of medication non-adherence included: expensive medications, prescription side
effects, forgetfulness, no noted blood pressure improvement, lack of access to a physician, lack
of transportation, and high pill frequency. Since adherence is the most common issue for
uncontrolled hypertension in African Americans, it is important to consider the Hill-Levine
Conceptual model (1999) for improving patient adherence to the individual’s treatment plan
(Figure 1) (Hill et al., 1999). Greer and Ostwald (2015) adapted the Hill-Levine’s Conceptual
Model to provide an educational hypertension program sensitive to the cultural attitudes and
beliefs of African American women. This conceptual model was utilized in the formation of the
educational phase of the HBPM program implemented in this translational research project.
The conceptual model (Figure 1) identifies predisposing, enabling, and reinforcing
factors as the foundation of the framework when building a culturally competent educational
program. This diagram represents the framework of the Hill-Levine Conceptual Model and the
steps it takes to improve medical adherence and achieve controlled hypertension. This
foundation helps the PI address current knowledge and positive or negative beliefs about
hypertension (predisposing factors). The conceptual model ensures the individual is provided
with the resources necessary to succeed in the program by assessing and providing health
behavioral skills (enabling factors). Lastly, the model incorporates the subject’s environment and
support systems for motivational help and guidance (reinforcing factors).
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Health Outcomes:
1. Controlled blood
pressure
2. Prevention of EndOrgan Damage.
Adherence to Treatment
Recomendations:
1. Maintain follow-up with care
provider.
2. Complete Home-based blood
pressure monitoring twice daily.
3. Take prescribed blood
pressure medications

Reinforcing Factors:
Social Support

Enabling Factors:
Healthcare resources,
health behavior skills

Predisposing
Factors: Knowledge,
Attitudes, and Beliefs

Figure 1: Hill-Levine’s Conceptual Model for Hypertension Management Adherence.

With these supportive factors the individual is provided with the recommendations for
successful program completion resulting in positive health outcomes. In this case it would be
controlled blood pressure and prevention of end-organ damage. This is a culturally effective
model, because it addresses the individuals’ issues and helps to reshape the person’s beliefs
while providing social support from their own environment. Greer and Ostwald (2015) study of a
culturally sensitive high blood pressure educational program among African American women
demonstrated a statistically significant (p=.006) decrease in blood pressure over six months
without any loss of participants, but the association between blood pressure and education were
not statistically significant (p>.05). While this theoretical framework focuses on the behaviors of
African American women, it provides practices that can benefit various cultures and individuals.
Nonetheless, the theoretical framework was utilized to formulate the educational platform for the
HBPM program to improve blood pressure monitoring adherence.
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Chapter III:
Project Design
The translational research project is a pre-test and post-test clinical trial of the
effectiveness of HBPM. Consent of the Georgia College & State University Institutional Review
Board (IRB) was obtained prior to beginning the recruitment of participants for this study. Consent

and site approval was obtained from a primary care non-profit community clinic in rural North
Georgia and a medical practice in suburban Central Georgia to implement study.
Sample
A convenience sample of participants 18 to 60 years old with pre-hypertension, newly
diagnosed or uncontrolled hypertension was identified for the project. The age group is limited to
18 to 60 based on the JNC VIII guidelines. According to the JNC VIII recommendations, elderly
persons greater than 60 years old are given a higher threshold of blood pressure (150/90) (Abel et
al., 2015). Physicians and practitioners from the two practices identified potential participants
and provided them with unmarked folders. The folders contained the proposed project with
HBPM education and consent forms for subjects to sign. Each informed consent was labeled
with an identification number, but however concealed until participant opened and signed
consent. The subjects were asked to read contents, sign informed consent, and submit consent
forms to the clinic manager. The researcher retrieved consents from clinic manager and verbally
confirmed consent with participants. The even numbered participants were a part of the
experimental group and the odd numbered participants a part of the control group.
Inclusion Criteria. The study sample included adult patients, male and female, 18 to 60
years old with pre-hypertension (>130/80), newly diagnosed or uncontrolled essential
hypertension (>140/90). The participants must have a pre-hypertension or hypertension diagnosis
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and be under the care of a physician for management. Each subject must be proficient in English
or have a professional interpreter, have access to email and Internet or be able to travel to the
clinic to submit results on a monthly basis. Lastly, participants must be physically capable of
taking their own blood pressure twice a day or have a family member willing to participate.
Exclusion Criteria. Subjects less than 18 years old or greater than 60 years old,
pregnant, blood pressure greater than 200/100, terminal disease, dementia, or hypertension not
managed by a physician.
Variables
Descriptive data was obtained from medical records and a demographic survey
(Appendix B). Descriptive variables defined in the study sample included gender, age, ethnicity,
quantity of blood pressure medications prescribed (QoBPM), weight, height, Body Mass Index
(BMI), tobacco use, pre-study HBPM use (PHU), past medical history (PMH), socio-economic
factors (SEF). Outcomes variables include Systolic Blood pressure (SBP), Diastolic Blood
pressure (DBP), high blood pressure knowledge scale (HBPKS), high blood pressure self-care
scale (HBPSCS), and Morisky’s Medication Adherence Scale (MMAS-8).
Project Phases
The translational care project was conducted over eight-weeks and was divided into three
phases: Educational Phase, Monitoring Phase, and Evaluation Phase. The healthcare providers
referred patients with pre-hypertension, newly diagnosed or uncontrolled hypertension to
participate in the project and given project information with informed consent. Once participants
signed and submitted informed consent, the PI contacted participants to schedule educational
sessions. Even numbered participants were a part of the experimental group and received blood
pressure monitors with their educational session, whereas the odd numbered participants were a
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part of the control group and received educational session only. Educational courses were
scheduled weekly on Tuesday’s from 5-7pm. Due to time constraints participants were scheduled
for education in small groups immediately upon enrollment. Due to low participation, an
additional practice site was added under the same guidelines as the initial practice site.
Phase 1: Staff Education. Education was provided to the clinical staff of each facility to
include: proper measurement techniques, monitoring home readings, and providing timely advice
for medication titration and lifestyle changes from the Eighth Joint National Committee (JNC
VIII) (James et al., 2014). The JNC VIII Algorithm was provided to physicians and providers as
a standard guide to follow in the treatment of hypertension (Figure 2).

HYPERTENSION MANAGEMENT WITH HBPM

26

JNC 8 Hypertension Guideline Algorithm
Initial Drugs of Choice for Hypertension
• ACE inhibitor (ACEI)
• Angiotensin receptor blocker (ARB)
• Thiazide diuretic
• Calcium channel blocker (CCB)

Adult aged ≥ 18 years with HTN
Implement lifestyle modifications
Set BP goal, initiate BP-lowering medication based on algorithm
General Population
(no diabetes or CKD)

Diabetes or CKD present

Strategy
Age ≥ 60 years

Age < 60 years

BP Goal
< 150/90

BP Goal
< 140/90

Nonblack
Initiate thiazide, ACEI, ARB,
or CCB, alone or in combo

All Ages
Diabetes present
No CKD

All Ages and Races
CKD present with or
without diabetes

BP Goal
< 140/90

BP Goal
< 140/90

Black
Initiate thiazide or CCB,
alone or combo

Start one drug, titrate to maximum
dose, and then add a second drug.

B

Start one drug, then add a second
drug before achieving max dose of
first

C

Begin 2 drugs at same time, as
separate pills or combination pill.
Initial combination therapy is
recommended if BP is greater than
20/10mm Hg above goal

Initiate ACEI or ARB,
alone or combo
w/another class

Yes

At blood pressure goal?
No

Reinforce lifestyle and adherence
Titrate medications to maximum doses or consider adding another medication (ACEI, ARB, CCB, Thiazide)
Yes

At blood pressure goal?
No

Reinforce lifestyle and adherence
Add a medication class not already selected (i.e. beta blocker, aldosterone antagonist, others) and titrate
above medications to max (see back of card)
At blood pressure goal?

Yes

Description

A

Lifestyle changes:
• Smoking Cessation
• Control blood glucose and lipids
• Diet
Eat healthy (i.e., DASH diet)
Moderate alcohol consumption
Reduce sodium intake to no
more than 2,400 mg/day
• Physical activity
Moderate-to-vigorous activity
3-4 days a week averaging 40
min per session.

Continue tx and monitoring

No

Reinforce lifestyle and adherence
Titrate meds to maximum doses, add another med and/or refer to hypertension specialist

Reference: James PA, Ortiz E, et al. 2014 evidence-based guideline for the management
of high blood pressure in adults: (JNC8). JAMA. 2014 Feb 5;311(5):507-20
Card developed by Cole Glenn, Pharm.D. & James L Taylor, Pharm.D.

Figure 2: JNC VIII Medication and lifestyle change algorithm (James et al., 2014).

Phase 1: Participant Education. Participants recruited were assigned to their
educational course based on their assigned identification number. The experimental group was
provided with the same blood pressure monitors to minimize variance. Both groups received the
same education regarding: definition of hypertension, importance of blood pressure management,
proper measurement techniques, frequency of blood pressure monitoring, and blood pressure
management protocol. Patient and staff educational materials included:
Agency for Healthcare Research and Quality’s (AHRQ) Measuring Your Blood pressure at
Home: A Review of the Research for Adults (2012);
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American Heart Association’s (AHA, 2012) How to Monitor and Record Your Blood
pressure;

•

AHA’s (2012) Instructional Video: Monitoring Blood pressure at Home.

All tools utilized for education were created and supported by the CDC (2014) and are available
free of charge on the CDC’s website “Self-Measured Blood pressure Monitoring Action Steps
for Clinicians.” A pre-education baseline test was conducted to assess participants’ blood
pressure knowledge and self-care abilities utilizing Peters and Templin (2008) Blood pressure
Knowledge Scale and Blood pressure Self-Care Scale.
All participants were provided with a Flagging system using the American Heart
Association’s hypertension categories will be provided to participants to assure patients are
aware of what their blood pressure means and how they should act upon the results (Figure 3).
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Blood pressure
Category
Normal
Prehypertension
High Blood pressure
(Hypertension) Stage 1
High Blood pressure
(Hypertension) Stage 2
Hypertensive Crisis
(Emergency care needed)

Systolic
mm Hg (upper #)
less than 120
120 – 139
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and
or

Diastolic
mm Hg (lower #)
less than 80
80 – 89

140 – 159

or

90 – 99

160 or higher

or

100 or higher

Higher than 180

or

Higher than 110

Figure 3: Flagging System (AHA, 2016a).

1.

Green * (Normal)- Great job, your blood pressure is normal. Keep monitoring your bp twice daily.

2.

Yellow (Pre-Hypertension)- Your blood pressure is slightly elevated. Did you take your bp medications,
have a high sodium meal, are you stressed? Keep monitoring your bp twice daily and taking medications as
prescribed.

3.

Orange (Stage 1)- Your blood pressure is elevated. Did you take your bp medications, have a high sodium
meal, are you stressed? Your provider may need to change your blood pressure medication. Keep
monitoring your bp twice daily and taking medications as prescribed.

4.

Red (Stage 2)- Your blood pressure is very elevated. You should call your provider to schedule an
appointment or discuss your bp medication regimen. Keep monitoring your bp twice daily.

5.

Red (Hypertensive Crisis)- Caution, CALL 911

*if your pressure is <100/50, please notify your physician. If you begin to experience lightheadedness or dizziness
please go to your nearest emergency department or call 911.

Phase 2: Monitoring. After the educational phase patients were given the tools needed to
monitor their blood pressures at home twice daily at 12 hours a part. The experimental group was
expected to submit results to researcher for review monthly. The results were able to interface
into Omron’s Wellness App, a HIPAA approved health information technology program
accessible to those provided with the Omron blood pressure monitor. The Participants’ pre
HBPM implementation blood pressure results were compared to post HBPM results to determine
effectiveness of HBPM program. The PI was available in the clinic once a week and via phone
for troubleshooting needs and for those without access to Internet or email. If participants were
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unable to submit results via email or during PIs available hours at the clinic, individuals were
contacted to schedule a time to retrieve records.
The control group received the same education as the experimental group, but did not
receive blood pressure monitors. Participants among the control group were encouraged to obtain
a home monitor and monitor home results with a blood pressure results handout to write in
results twice daily. Blood pressure results were submitted to their health care provider during
follow-up and the researcher reviewed the results in the EHR.
Instruments
Demographic Data
The socio-demographics of the study sample were examined utilizing a demographic
survey constructed by the researcher (Appendix A). The demographic information that was
collected on the participants included: gender, age, ethnicity, quantity of blood pressure
medications prescribed, weight, height, Body Mass Index (BMI), tobacco use, pre-study HBPM
use, past medical history, socio-economic factors (education, marital status, employment status,
household income and health insurance status). This information was used to describe the sample
and for later data analysis.
Blood Pressure Monitor
Omron medical equipment has a reputation of providing quality medical grade
equipment. The Omron BP786 monitor was tested and passed according to the protocols of The
Association for the Advancement of Medical Instruments (AAMI) and the European Society of
Hypertension (ESH) ("10 Series Upper Arm Blood Pressure Monitor," 2016). The Omron 10
Series has the ability to take three consecutive blood pressure readings over ten minutes, and
averages the results for an accurate and reliable reading. The blood pressure monitor features an
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“easy wrap ComFit Cuff, extra large display, and is able to save 200 readings” ("10 Series Upper
Arm Blood Pressure Monitor," 2016, p. 1). The Omron BP786 is a sphygmomanometer model
that is capable of transmitting data to the Omron Wellness application. Participants are then able
to submit results via email through the application and to the patient's provider via a HIPAA
approved information system. This eliminates the tediousness of writing and need for patients to
keep a written log, which helps prevent the misinterpretation of results due to poor writing
legibility or lack of memorization. The monitor is able to store results by keeping an electronic
record of accurate blood pressure results that can be easily accessed and reviewed. This will
allow the practitioner to be able to utilize supporting data to institute the best intervention
necessary for treatment of the patient’s blood pressure. Topouchian et al. (2014) documents the
validity of the Omron BP786 demonstrating less than 5 mmHg differences in SBP and DBP
results based on the AAMI’s and ESH’s protocol.
Knowledge and Self-care Scale
Peters and Templin (2008) developed the Blood Pressure Knowledge (KS) and Self-Care
(SC) scales utilizing the self-care deficit nursing theory by Orem (Appendix B). The scales were
utilized in this translational research project to measure participants’ knowledge and self-care
practices pre-education and post-HBPM intervention. This instrument helps measure the
effectiveness of the phase one participant educational session to determine if hypertension
lifestyle (low fat and salt diet, diet high in fruits and vegetables, daily 30-min physical activity,
minimal stress, healthy weight, minimal alcohol and tobacco use, doctor follow-up, and
medication adherence) changes had improved.. The Blood Pressure Knowledge Scale and the
Blood pressure Self-Care Scale were 11 and 10-item questionnaires respectively (Peters &
Templin, 2008). The Knowledge Scale assesses the comprehension and belief that particular
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behaviors improve blood pressure results and the Self-care Scale assesses how often the
participants perform the specific behaviors (Peters & Templin, 2008). The behaviors analyzed
included: maintaining a healthy diet, increased physical activity, stress management, weight
management, avoiding alcohol or tobacco use, doctor follow-up and medication adherence. The
scales utilized a seven-point bipolar scale from 1 to 7, measuring from “strongly disagree” to
“strongly agree” for the knowledge scale and “never” to “always” for the self-care scale (Peters
& Templin, 2008) (Appendix C). Some of the items are reverse coded with a total scale range
from 11 to 77 for the Knowledge scale and 9 to 70 for the Self-Care scale (Peters & Templin,
2008). The scales are valid and reliable demonstrating a Cronbach’s alpha of 0.85 (KS) and 0.7
(SC) (Peters & Templin, 2008). The authors gave the researcher permission to utilize these scales
in this translational research study.
Morisky’s Medication Adherence Scale
Medication adherence was measured pre and post intervention to answer the clinical
question of whether HBPM in patients with hypertension increase adherence to blood pressure
monitoring and medication compliance. Krousel-Wood et al. (2009), Morisky, Ang, KrouselWood, and Ward (2008), and Morisky and DiMatteo (2011) established Morisky’s Medication
Adherence Scale (MMAS-8), which is an eight-item scale to assess medication adherence in
patients with various chronic diseases including hypertension (Appendix C). The scale utilizes a
“yes” and “no” response for items 1-7 and for item 8 a five-point Likert scale is utilized
measuring from “never/rarely” to “all the time” (Krousel-Wood et al., 2009; Morisky et al.,
2008; Morisky & DiMatteo, 2011). Some of the items are reverse coded with a total scale range
from 0 to 8, with 8 equivocating to high adherence, 6 to 8 medium adherence, and less than 6
low adherence (Krousel-Wood et al., 2009; Morisky et al., 2008; Morisky & DiMatteo, 2011).
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The MMAS-8 has shown to be valid and reliable according to Pérez-Escamilla, Franco-Trigo,
Moullin, Martínez-Martínez, and García-Corpas (2015). The Pérez-Escamilla et al. (2015)
literature review compared several medication adherence instruments, but Morisky’s had the
highest validity and reliability with a Crohnbach’s alpha of 0.83. Appendix D displays the
questionnaire developed by Krousel-Wood et al. (2009), Morisky et al. (2008), and Morisky and
DiMatteo (2011), which is copyrighted. The authors gave the researcher permission with a
written agreement to utilize this scale for this translational research study.
Protection of Human Subjects
Informed consent was obtained prior to the initiation of the translational research project
(Appendix F). The information and consent forms were provided to the prospective participants.
The participants signed and submitted consent forms to the clinic manager and were returned to
the PI. Each participant was provided a copy of the informed consent for his or her records.
Information security and patient information protection is important in the process of this
translational project. To ensure data is protected in accordance to the Health Insurance
Portability and Accountability Act (HIPAA) privacy rule and the Georgia College & State
University’s Institutional Review Board (GCSU IRB) by which this project was approved, the
researcher did the following:
1. The clinician established an ID number for each participant. The ID number and code-list
will be kept separately on paper and via an electronic file.
2. All paper work, code-list, signed consents, and written surveys will be kept in a locked
file drawer in a locked and secure office.
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3. Any electronic files kept on the clinician’s computer will be password protected as well
as the computer itself. Data files on the computer will be encrypted by Apple’s OS X
folder encryption software.
4. Any back-up files and data that will be saved on a portable drive will also be password
protected. Again, data files on the computer will be encrypted by Apple’s OS X folder
encryption software.
5. Any lost or stolen information or property will be reported to GCSU’s IRB immediately
and handled per the institution’s protocol.
6. All patient data will be kept and securely stored for three years following the research
study. After three years the data will be deleted and destroyed.
There were no immediate risks associated with home-based blood pressure monitoring.
However, being diagnosed and treated for hypertension comes with risks of psychological stress
and physical damage to the heart and arteries. The researcher facilitated emotional and
psychological support throughout the study of HBPM. The introduction of the study began with
HBPM education. The participants were encouraged to bring family or friends to the education
for social support. The education provided the participants with an introductory knowledge basis
to HBPM and an opportunity to become comfortable with home monitoring and also provides
and opportunity of social support with other individuals with a similar diagnosis.
The flagging system was a proactive measure to ensure patients were equipped with the
materials necessary to monitor and evaluate their blood pressures on a daily basis. The flagging
system was a reference tool with the necessary advisory instructions for the participant to
reference every time the blood pressure was taken. The reference tool also provides supportive
measures to help prompt the patient in critically analyzing reasons for changes in BP. Signs and
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symptoms that were discussed with participants that would require immediate medical attention
included: chest discomfort, shortness of breath, facial drooping, sudden severe headache, arm
weakness, speech difficulty, nausea/vomiting, lightheadedness, or dizziness. If any of these
symptoms occurred, patients were instructed to call 911, immediately. One participant was
discontinued from the study for safety measure.
Data Analysis Plan
Phase 3: Post Evaluation
Descriptive and outcomes data was first cleaned and evaluated for missing data and
outliers. Missing data was identified via exploratory analysis and outliers via scatterplots,
boxplots and Z-scores. Descriptive statistics were used to describe the demographics of the
sample. Descriptive statistics included frequencies for nominal and ordinal level measurements
(gender, ethnicity, BMI, tobacco use, SEF, PMH, and PHU). For ratio level measurements (age,
weight, height, QoBPM, HBPKS, HBPSCS, MMAS, SBP, and DBP) mean, median, mode,
standard deviation, confidence intervals, kurtosis and skewness will be obtained to assess for
normality and central tendency. Internal consistency reliability of both instruments were
evaluated and discussed in the instruments section of this manuscript.
Clinical Question 1. Patients receiving the HBPM program will have lower blood
pressures at 60 days. SPSS Version 24 was used to conduct inferential statistics with the twotailed paired t-test. The two-tailed paired t-test is most operative in showing whether or not the
HBPM program is effective since this is a pre-test and post-test quasi-experimental study. A twotailed paired t-test will provide enough power to show whether the HBPM program is or is not
effective in the management of uncontrolled hypertension. The dependent variable, blood
pressure, is a ratio level of measurement and if normal distribution is true, this variable fits the
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assumptions for parametric testing. Results were assessed at multiple time points (four weeks
and eight weeks) to assess the progression of the study among the experimental group. Pre and
post HBPM intervention blood pressure results were compared among the experimental and
control groups. Analysis of Covariance (ANCOVA) testing was conducted to rule-out
confounding variables, for example, the variables age, kidney disease, and African American
men.
Clinical Question 2. Patients receiving the HBPM program will have increased
adherence to HBPM monitoring at 60 days. The number of missed data entries was tabulated for
each participant to evaluate monitoring adherence. Of the 60 days (120 data entries) the project
was implemented, each participant was allotted 12 missed data entries (10%). Greater than 12
missed data entries over the course of the project was considered decreased adherence to the
HBPM program.
Clinical Question 3. Patients receiving the HBPM program will have increased
adherence to hypertension lifestyle (low fat and salt diet, diet high in fruits and vegetables, daily
30-min physical activity, minimal stress, healthy weight, minimal alcohol and tobacco use,
doctor follow-up, and medication adherence) changes than those in the control at 60 days. Again,
SPSS Version 24 was used to conduct inferential statistics with the two-tailed paired t-test. A
pre-test and post-test of the knowledge scale and self-care scale was conducted to determine
whether or not the HBPM education and monitoring process improved patient education and
self-care skills. The dependent variables are the responses to the HBPKS and HBPSC surveys
which are ratio levels of measurement and if normal distribution is true, this variable fits the
assumptions for parametric testing. Pre and post survey responses will be compared among the

HYPERTENSION MANAGEMENT WITH HBPM

36

experimental and control groups to evaluate the effectiveness in improving hypertension
management adherence.
Clinical Question 4. Patients receiving the HBPM program will have higher adherence
to medication therapy than those in the control group at 60 days. Again, SPSS Version 24 was
used to conduct inferential statistics with the two-tailed paired t-test. A pre-test and post-test
medication adherence questionnaire was utilized to determine whether the HBPM program
improved medication adherence. Again, SPSS Version 24 was used to conduct inferential
statistics with the two-tailed paired t-test. The dependent variables are the responses to the
MMAS-8 survey, which are ratio levels of measurement. If normal distribution is true, this
variable fits the assumptions for parametric testing. Pre and post survey responses will be
compared among the experimental and control groups to evaluate the effectiveness in improving
hypertensive medication adherence.
Feasibility
Timeline
The timeframe was eight-weeks to successfully implement the translational care project.
The staff was educated on the HBPM process involving proper body mechanics and
hypertension management prior to the beginning of the study in person and via web-ex on July
26th. Due to time constraints, participant recruitment and project implementation occurred
simultaneously in small groups. As the provider referred participants, classes were assigned
based on the number labeled in their education and informed consent packer. The even numbered
participants were a part of the experimental group and the odd numbered participants were a part
of the control group. Educational courses were scheduled weekly on Tuesday’s from 5-7pm and
Thursday’s from 4-5:30pm for three months (August 2nd to October 11th). At the beginning of
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each seminar a pre-test Blood Pressure Knowledge Scale, Self-care Scale was completed and
MMAS-8 was conducted. HBPM began the day after education, where blood pressures were to
be taken twice daily, 12-hours a part. Each participants start date was recorded and tracked to
ensure prompt follow-up. The results were examined on a monthly basis by the researcher and
forwarded to the participants’ care provider. After eight-weeks of HBPM implementation, posttest Blood Pressure Knowledge Scale, Self-care Scale, and MMAS-8 was conducted in person,
via phone or email and data analysis began.
Budget
The researcher developed a Go Fund Me account
(https://www.gofundme.com/HBPM2016) and collected $1,920 to purchase blood pressure
monitors for the participants. The researcher also received two scholarships through Georgia
College and State University from the Carolyn M. Maynard Nursing Scholarship fund and the
Marjorie G. Prentice Graduate Research Scholarship fund for a total of $893. Funding helped
provide blood pressure monitors to patients and cover costs related to educational materials. The
total cost of the blood pressure monitors was $3041.48 for the entire sample population after a
discount provided by Omron Healthcare.
Benefit
Home-based blood pressure monitoring is innovative technology that will help health
care providers deliver individualized patient care based on accurately reported blood pressure
results. This project is the beginning of future large scaled projects. A HBPM program can be
costly and therefore proper implementation is essential. Yet, compared to the billions of dollars
spent on hypertension, treatment, and co-morbid conditions; improved blood pressure control
will decrease the prevalence of co-morbid conditions and decrease health care costs. The HBPM
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program decreases patient expenditures due to decreased in-office visits and co-pays and
decreased transportation needs or time off work. HBPM also has the potential to increase
revenue to the health care practice for virtual visits. Often patients are lost to follow-up due to
conflicting schedules and transportation (Young et al., 2015). HBPM with telecommunication
management provides an avenue for more timely, effective, and individualized patient care.
According to the CDC (2014), Medicare Part B, Medicare Part C, Medicaid, and private
insurance provide coverage for Ambulatory Blood Pressure Monitoring for diagnostic accuracy
of hypertension, whereas, in most insurance plans, HBPM coverage is limited. With an increase
in successful studies, such as the one proposed, legislation could be initiated to increase coverage
and reimbursement cost of HBPM programs.
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Chapter IV:
Results
The results of this pre-test and post-test clinical trial of HBPM are discussed in this
chapter. Findings reported here include descriptive statistics concerning the sample of
participants and data addressing the research questions. Data screening was performed prior to
conducting the statistical analyses in SPSS Version 24. Data was verified utilizing a double entry
method where two separate databases were created and compared to identify discrepancies.
Inconsistencies were then reconciled with the participants’ original data and a substitution method
was utilized for missing data.
Examination of all continuous variables was conducted to determine normal distribution
using descriptive statistics for central tendency, Fisher’s exact for skewness and kurtosis, histogram,
Q-Q normality plots, Kolmogorov-Smirov test, and Shapiro-Wilk test. Each variable either exhibited
normality or near normal distribution and therefore parametric testing was utilized to evaluate the
results. The student t-test and Chi-square (X2) test were conducted to determine whether a covariate
existed among the variables of age, gender, ethnicity, and past medical history of chronic kidney
disease. The results were insignificant for all potential covariates and therefore no covariates were
controlled for in hypothesis testing.

Sample Characteristics
A total of 20 adults participated in the HBPM program. While initially the inclusion
criteria for the study limited the participant age range to 18-60 years old, in the interest of the
protection of human subjects and the ethical principle of justice, all ages were accepted into the
study. Data was collected and analyzed for the entire sample since the purpose of the HBPM
program was to demonstrate an improvement in blood pressure and adherence to the program,
not to achieve a specific threshold as designated by the JNC VIII guidelines. Those meeting the
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inclusion criteria were randomized into the experimental (n=11) and control group (n=9) as
demonstrated in Figure 4, the CONSORT Flow Diagram (Altman et al., 2001). The flow diagram
outlines the flow of participants throughout the project revealing the forfeiture of two
participants both due to lost to follow up. One participant did not submit results and researcher
was unable to reach participant and the other discontinued due to hospitalization for hypertensive
emergency. Data analysis was completed on all 20 participants. For the two participants whom
did not complete the study, post-intervention data entries were substituted using their preintervention results.
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Assessed for eligibility (n= 20)

Excluded (n= 0)
• Not meeting inclusion criteria (n= 0)
• Declined to participate (n=0)
• Other reasons (n= 0)

Randomized (n= 20)

Allocation
Allocated to Intervention group (n= 11)
• Received allocated intervention (n= 11)
• Did not receive allocated intervention (n= 0)

Allocated to Control group (n= 9)
• Received allocated intervention (n= 9)
• Did not receive allocated intervention (n= 0)

Follow-Up
Lost to follow-up (n= 2)*
• Did not submit results and unable to reach
participant.
• Hospitalized for hypertensive emergency.

Lost to follow-up (n= 0)
Discontinued intervention (n=0)

Analysis
Analysed (n= 11)
• Excluded from analysis (n= 0)

Analysed (n=9)
• Excluded from analysis (n= 0)

Figure 4: CONSORT Flow Diagram (Altman et al., 2001).
*Participants were lost to follow-up at 30 days. All participants’ pre-intervention data was analyzed; the two participants lost to follow-up had
missing data for the 60-day data analysis.

HYPERTENSION MANAGEMENT WITH HBPM

42

The participant’s demographics, medical history, lifestyle, and socio-economic status are
described in detail in Table 1. The study participants were primarily male (55%), Caucasian
(45%), or African American (40%). Two participants were Hispanic (10%) and one “Other”
(5%). Participants’ ages ranged from 35 to 82 with a mean age of 58.05 (SD = 12.88). Regarding
lifestyle, a majority of the sample was considered overweight (50%) with a BMI of 25 to 29.9 (M
= 31.0) and weight ranging from 141lbs to 270lbs; only one participant was a normal BMI (5%).
A large percentage of participants did not use tobacco products (75%). Concerning pre-existing
conditions that could cause hypertension, participants were positive for a history of Type 2
Diabetes Mellitus (75%), hyperlipidemia (50%), CKD (55%) and sleep apnea (20%).
Participants on average had 2.8 (SD = 1.9) blood pressure medications prescribed.
Regarding the sample’s socio-economic status, a majority were high school graduates/GED
equivalent (30%) or had a Bachelor’s degree (25%), married (50%), employed (40%) or retired
(40%), uninsured (35%) or under a federally funded insurance program like Medicare (35%)
with a mean household income of $34363.20 (SD = 25033.40). Overall, prior to the initiation of
this research project, sixty percent of the sample had been performing some type of blood
pressure monitoring at home.
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Table 1
Descriptive Statistics of Sample Characteristics (n=20)
Participants
Total Group
(n = 20)

Experimental
Group
(n = 11)

Control
Group
(n = 9)

Male

11 (55)

5 (45.5)

6 (66.7)

Female

9 (45)

6 (54.5)

3 (33.3)

58.1 (12.9)

50.5 (9.3)

67.3 (10.44)

Caucasian

9 (45%)

3 (27.3)

6 (66.7)

Hispanic/Latino

2 (10%)

2 (18.2)

0 (0)

African American

8 (40)

5 (45.5)

3 (33.3)

Native American

0 (0)

0 (0)

0 (0)

Characteristics, n
Gender, n (%)

Age M, (SD)
Ethnicity, n (%)

Asian

0 (0)

0 (0)

0 (0)

Other

1 (10)

1 (9.1)

0 (0)

Some High School (no degree)

1 (5)

1 (9.1)

0 (0)

High School Graduate/GED

6 (30)

5 (45.5)

1 (11.1)

Some College (no degree)

4 (20)

1 (9.1)

3 (33.3)

Trade School

2 (10)

2 (18.2)

0 (0)

Bachelor’s

5 (25)

0 (0)

5 (55.6)

Master’s

1 (5)

1 (9.1)

0 (0)

Doctoral

1 (5)

1 (9.1)

0 (0)

Single

2 (10)

2 (18.2)

0 (0)

Married

10 (50)

4 (36.4)

6 (66.7)

Widowed

2 (10)

0 (0)

2 (22.2)

Divorced

4 (20)

3 (27.3)

1 (11.1)

Separated

2 (10)

2 (18.2)

0 (0)

Employed for Wages

8 (40)

7 (63.6)

1 (11.1)

Self-Employed

1 (5)

0 (0)

1 (11.1)

Unemployed

1 (5)

1 (9.1)

0 (0)

Homemaker

1 (5)

1 (9.1)

0 (0)

Retired

8 (40)

1 (9.1)

7 (77.8)

1 (5)
34363.20
(25033.40)

1 (9.1)
27528.36
(27776.17)

0 (0)
42716.89
(19524.57)

7 (35)

6 (54.5)

1 (11.1)

Educational Level, n (%)

Marital Status, n (%)

Employment Status, n (%)

Disabled
Total Household Income, M (SD)
Health Insurance Status, n (%)
Uninsured
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(Table 1 continued)
Employment-Based Plan

3 (15)

3 (27.3)

0 (0)

Direct-Purchase Private Plan

2 (10)

1 (9.1)

1 (11.1)

Medicare

7 (35)

0 (0)

7 (77.8)

Medicaid

1 (5)

1 (9.1)

0 (0)

2.8 (1.9)

1.9 (1.4)

3.9 (1.97)

Yes

13 (65)

6 (54.5)

7 (77.8)

No

7 (35)

5 (45.5)

2 (22.2)

Diabetes Type 1

0 (0)

0 (0)

0 (0)

Diabetes Type 2

15 (75)

7 (63.6)

8 (88.9)

Hyperlipidemia

10 (50)

3 (27.3)

7 (77.8)

Chronic Kidney Disease

11 (55)

4 (36.4)

7 (77.8)

Sleep Apnea

5 (25)

0 (0)

5 (55.6)

Yes

5 (25)

3 (27.3)

2 (22.2)

No

15 (75)

8 (72.7)

7 (77.8)

31.0 (5.4)

31.6 (6.7)

30.4 (3.4)

Baseline-Systolic BP

158.9 (12.8)

154.5 (8.7)

164.2 (15.2)

Baseline-Diastolic BP

90.2 (13.1)

93.7 (7.2)

85.8 (17.3)

Post-Systolic BP

142.9 (19.1)

145.8 (19.3)

139.2 (19.2)

Post-Diastolic BP

81.6 (12.5)

87.8 (7.9)

74 (13.2)

67.7 (9.8)

69.6 (9.8)

65.4 (9.8)

67 (8.1)

66.5 (8.7)

67.7 (7.7)

Baseline-SCS

46.3 (11.5)

48.0 (13.3)

44.3 (9.1)

Post-SCS

51.0 (8.6)

50.6 (9.7)

51.3 (7.7)

Baseline-MMAS

5.7 (1.9)

5.88 (1.83)

5.4 (2.0)

Post-MMAS

5.9 (1.6)

5.86 (1.64)

5.9 (1.7)

Quantity of BP Meds Prescribed, M (SD)
Currently Monitoring HBPM, n (%)

Past Medical History, n (%)

Tobacco Use, n (%)

BMI, M (SD)
Blood Pressure (BP), M (SD)

Knowledge Scale (KS), M (SD)
Baseline-KS
Post-KS
Self-Care Scale (SCS), M (SCS)

MMAS, M (SD)

Note. n = Total participants, % = percentage, M = Mean, SD = Standard deviation, meds = medications,
MMAS = Morisky’s Medication Adherence Scale.
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Clinical Question 1
An independent samples t-test was used to test the hypothesis that patients receiving the
HBPM program will significantly lower blood pressure at 60 days than those in the control
group. This hypothesis was not supported. Patients receiving the HBPM program had higher
systolic blood pressures (M = 145.8, SD = 19.3) than those in the control group [(M = 139.2, SD
= 19.2), t(18) = -.76, p = .456] at 60 days. Similarly, patients receiving the HBPM program had
significantly higher diastolic blood pressures (M = 87.8, SD = 7.94) than those in the control
group [(M = 74.0, SD =13.2), t (18) = -2.9, p = .010] at the 60-day blood pressure re-evaluation.
Clinical Question 2
An adherence scale was developed to determine whether patients receiving the HBPM
program had increased adherence to HBPM monitoring. For each day the participant checked
their blood pressure two points were accumulated, with a total possible score ranging from 0120. Adherence was split into three categories, Low 0-40 (15%), Moderate 41-80 (15%), and
High Adherence >81 (45%). An independent sample t-test was used to determine whether
patients receiving the HBPM program had higher adherence to blood pressure monitoring at 60
days. This hypothesis was supported. Patients receiving the HBPM program had higher HBPM
adherence scores (M = 70.1, SD = 43.74) than the control group [(M = 46.0, SD = 52.8), t (18) =
-1.117, p = .279] at 60 days.
Clinical Question 3
An independent sample t-test was used to determine whether patients receiving the
HBPM program had higher adherence to hypertension lifestyle (low fat and salt diet, diet high in
fruits and vegetables, daily 30-min physical activity, minimal stress, healthy weight, minimal
alcohol and tobacco use, doctor follow-up, and medication adherence) changes at 60 days. This
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hypothesis was not supported. Patients receiving the HBPM program had lower self-care survey
scores (M = 50.6, SD = 9.74) than the control group [(M = 51.33, SD = 7.66), t (18) = .175, p =
.863] at 60 days. Similarly, patients receiving the HBPM program had lower knowledge scale
survey scores (M = 66.45, SD = 8.7) than the control group [(M = 67.67, SD = 7.7), t (18) = .326,
p = .748] at the end of 60 days.
Clinical Question 4
An independent samples t-test was used to determine whether patients receiving the
HBPM program had higher adherence to medication therapy than those in the control group at 60
days. This hypothesis was not supported. Patients receiving the HBPM program had lower
medication adherence survey scores (M = 5.86, SD = 1.73) than those in the control group [(M =
5.88, SD = 1.64), t (18) = .033, p = .974] at 60 days.
Summary
An analysis of a sample of 20 hypertensive patients enrolled in a structured HBPM
program was completed. For clinical question 1, inferential statistics demonstrate a statistically
insignificant increase in systolic blood pressure, but a statistically significant increase in diastolic
blood pressure between the experimental and control groups at 60 days. There was no statistical
significance in the improvement of HBPM adherence, knowledge, self-care, or medication
adherence in clinical questions 2, 3, and 4 between the two groups at 60 days.
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Chapter V
Discussion
The rising prevalence and mortality rate of hypertension makes this an important health
care issue to address (CDC, 2015). To help address the CDC’s (2015) initiatives to prevent, treat
and control hypertension, it is necessary to identify strategies like HBPM to improve blood
pressure monitoring in the treatment of hypertensive patients. Based on the data analysis, a
statistically significant improvement in blood pressure management, monitoring adherence,
knowledge, self-care, and medication adherence was not achieved in the implementation of
HBPM compared to hypertensive patients who did not receive the intervention. However, while
enhanced monitoring adherence was demonstrated among the experimental group, it was not
statistically significant.
While the findings suggest there is no statistical support for the use of HBPM in practice,
the translational research project is relevant in that it establishes a guide to implementing HBPM
into practice and addressing hypertension management. The results are not relative to similar
studies in that the study was underpowered and should be re-examined with a larger sample size.
In comparison to similar HBPM studies with an adequate sample size, a statistically significant
average decrease of 30.5 mmHg (p=0.002) in systolic blood pressure occurred in one study
(McManus et al., 2010) and a 12-point reduction in systolic blood pressure was demonstrated at
12 months in another study (McManus et al., 2014). Crabtree & Stuart-Shor (2014) demonstrated
a 60% improvement in a 12-month study of HBPM. Differences between these studies and the
current study are the implementation timeframe and sample size, demonstrating a few of the
constraints of this study.
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Limitations
There were several limitations of this study to be discussed. The first obstacle was limited
funding for the purchase of blood pressure monitors. A-priori power analysis was conducted for
a two-tailed t-test indicated that 128 participants were desired to achieve statistical significance.
The initial goal for the study was to have one large cohort of participants to obtain the power
analysis. However, funding was required to purchase the amount of blood pressure monitors
needed to fulfill the study a-priori sample size. Therefore, the researcher sought grants, investors,
and scholarship funding for the purchase of the monitors for 128 participants. The short length of
time from the planning phase to implementation of the project made it difficult to sequester the
amount of funding necessary to purchase the blood pressure monitors. Many grants that were
inquired about required at least a one-year timeframe before funds were distributed. Therefore, a
Go Fund Me was established for the procurement of funding, which required additional time for
growth. Once the allotted donations and scholarships were obtained a budget was created. The
study sample size, a-priori, was reevaluated to preclude developing a control group whom would
not receive a blood pressure monitor. The time required to obtain the funding necessary to
implement the project delayed the time available for the implementation phase of this
translational research project and therefore was shortened to 60 days.
Recruitment of participants for this study was difficult due to practice accessibility.
Initially, the researcher contacted several primary practices to implement the study. While there
was great interest in the study, it was difficult to find stakeholders in the research project.
Specifically, one particular practice declined to participate due to being in between medical
directors and not being able to facilitate the study during the timeframe required. Eventually,
two sites confirmed interest and provided site approval for the HBPM project. Unfortunately,
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one site cancelled their participation just prior to the implementation of the project due to
changes in practice dynamics. Therefore, implementation went forward with one practice site
approval, making participant recruitment limited. Approximately four weeks in the
implementation process a second practice site was added to recruit additional participants
however time for recruitment, project implementation, and data analysis was limited for this
practice group.
In addition to a small sample size, this is a convenience sample, which has the potential
to introduce bias, which decreased the statistical significance of the study. While the participants
were randomly assigned to the control and experimental groups, they were recruited from two
practice sites that cannot represent the population of hypertensive patients. Convenience samples
tend to misrepresent the population as a whole and are not ideal in the research process. A
complete randomized control study with an adequate sample size over a longer period of time
would strengthen the study design and more likely provide results similar to studies identified in
the literature review.
Strengths
While the sample size was inadequate to provide statistical significance of the pre-test
and post-test effectiveness of HBPM, it is a potential pilot for future studies. On a small scale,
the study conducted helps evaluate practicability, time, cost-effectiveness, complications, and
effect size to implement and sustain successful large-scale study designs in the future. Therefore,
the potential funding sources for the purchase of blood pressure devices identified in this
translational research project would benefit future research opportunities. Also, the methodology
of this project provides the phases necessary to incorporate a well-structured HBPM program
into practice. For instance, the resources and references identified in this translational research
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project can be utilized to construct a hypertension educational program for patients and staff
whom are key stakeholders in the success of similar research studies.
Future Research
Future research is necessary to analyze the effectiveness of a HBPM program. Future
studies can incorporate the existing HBPM program, model and tools to examine blood pressure
results among a larger sample over a longer period of time. Recruiting participants from larger or
multiple institutions could expound the sample size. Utilizing multiple facilities allows the
experimental and control groups to then be randomized on a per facility basis. For studies with
larger sample sizes, more researchers would be necessary to properly distribute the workload. A
larger sample size would improve statistical significance and improve generalizability of results.
In addition to a larger sample, other studies that demonstrated significant improvement in blood
pressure monitored results for 6 to 12 months. A longer study period would allow for the
collection of more data for a more accurate data analysis.
The models and tools utilized in this study can be easily replicated to evaluate various
settings and cultures. The translating evidence into research model by Pronovost, Berenholtz,
and Needham (2008) is a simple model that can be utilized in translating knowledge into practice
regardless of setting or culture. Whereas, the Hill-Levine’s Conceptual Model for Hypertension
Management Adherence was a conceptual model formulated to improve hypertension
management strategies among African American women (Hill et al., 1999). For the purposes of
this study, this model was utilized to structure a proper educational program, however, future
studies would benefit form utilizing this model to analyze HBPM adherence among African
Americans.
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In relationship to adherence, it appears that HBPM improved monitoring adherence.
While the experimental group had higher blood pressure results (with a significantly higher
diastolic blood pressure) than the control group, this could be due to the small sample size or
possibly due to stressors implicated by having to evaluate blood pressures in the home. Future
studies should be challenged to perform qualitative studies to explore patient perceptions of the
program. As advances in telemonitoring continue to make large strides, analysis of selfmonitoring and self-care in hypertension management should be assessed to ensure patients are
receiving quality care and meeting their own health care expectations.
Blood pressure monitors for HBPM can be quite expensive, especially for validated
monitors that provide the integration of mobile applications for transmitting data. With a
majority of health disparities occurring in underserved areas, future studies should examine the
cost effectiveness of HBPM and determine methods in which to increase affordability. Since
HBPM provides improved individualized care without the expenditure of excessive resources,
governmental agencies should be challenged to increase coverage and reimbursement cost of
HBPM programs.
Sustainability Analysis
Training of the staff on the implementation of the home-based blood pressure monitoring
program was instrumental in sustaining the life of this project. Incorporating the staff in the
patient education of HBPM and providers in the supervision of the program provides a
foreground for the stability and future of HBPM in the practices. The program also utilizes
protocols and algorithms from national organizations such as the American Heart Association
(AHA) and Center’s of Disease Prevention and Control (CDC) that will allow for continued
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access to reference tools and updates. The researcher will remain available for further assessment
and revamping of the program as needed.
Implications for Nursing Practice
With rising difficulties in the access to affordable health care, telemonitoring is essential
to the improvement of patient outcomes. HBPM is an innovative intervention that helps
providers administer individualized patient care based on accurately reported blood pressure
results without frequent in-office follow-ups. Successful HBPM implementation requires social
support and the translational research project demonstrates the importance of conducting home
monitoring in a supportive environment. Therefore, properly trained nursing staff by doctoral
prepared nurse clinicians is instrumental in ensuring patients and staff members are receiving the
proper education, instruction and tools necessary to successfully implement HBPM. The
translational research project implicates a feasible systematic approach to developing a
successful nurse-led HBPM program into practice.
Nurses, researchers, and translational research clinicians play an integral part in the
education, prevention, and management of chronic diseases. Nurses are at the forefront in the
clinical setting and represent the individuals actively implementing evidence-based practice
guidelines. In regards to HBPM, they are responsible for accurately obtaining blood pressures
and being able to demonstrate proper HBPM techniques, as well as, acknowledging processes
that are ineffective in the clinical setting. Doctor of nursing practice (DNP) researchers
disseminate research into practice and are capable of identifying robust evidence-based research
to effectively change policy and procedures. DNP researchers may conduct a literature review to
identify improved methods of blood pressure monitoring or implementation practices.

HYPERTENSION MANAGEMENT WITH HBPM

53

Collaboration efforts between PhD and DNP prepared nurses is essential in the development and
implementation of new HBPM practices.
Conclusion
The purpose of the translational research project was to determine the effectiveness of
home-based blood pressure monitoring in the management of pre-hypertension, newly
diagnosed, or uncontrolled hypertension. Based on the data analysis, a statistically significant
improvement in hypertension management was not achieved in the implementation of a HBPM
program. While there is limited statistical support for this translational research project, other
resources support HBPM as an innovative program that has the potential to provide healthcare
providers an avenue for more timely, effective, and individualized patient care. Literature
demonstrates that improved blood pressure control has the potential to decrease the prevalence of
co-morbid conditions and decrease health care costs. With an increase in successful studies
legislation could be challenged to increase coverage and reimbursement cost for blood pressure
monitors and more HBPM programs in practice. Continued research related to HBPM and
patient adherence is necessary to improve patient access to affordable care and overall self-care
outcomes.
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Appendix A
Demographic Survey
Principle
Investigator: Nicole Bello

ID #:
Date:

Carefully read each question answer most appropriately.
1. What is your gender?
A. Male
B. Female
2. What is your age?_________
3. Please specify your ethnicity:
A. White
B. Hispanic/Latino
C. Black/African American
D. Native American/American Indian
E. Asian/Pacific Islander
F. Other
4. Weight ___________
5. Height ____________
6. Use of Tobacco products? Yes/No
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7. How many blood pressure medications do you take? ___________
8. Do you currently monitor your blood pressure at home? Yes/No
9.

What is the highest degree or level of school you have completed? If currently enrolled,
highest degree received.
A. Some high school, no diploma
B. High school graduate, diploma or the equivalent (GED)
C. Some college, no degree
D. Trade/Technical school
E. Associates degree
F. Bachelor’s degree
G. Master’s degree
H. Professional degree
I. Doctoral degree

10. What is your marital status?
A. Single, never married
B. Married/domestic partnership
C. Widowed
D. Divorced
E. Separated
11. What is your occupation?
A. Employed for wages
B. Self-employed
C. Unemployed and looking for work
D. Unemployed and not currently looking for work
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E. A homemaker
F. A student
G. Military
H. Retired
I. Disabled
12. What is your total household income?______________
13. What is your health insurance status?
A. Uninsured
B. Employment-based private plan
C. Direct-purchase private plan
D. Medicare
E. Medicaid
F. Military health plan
14. Have you ever been diagnosed with_____? (Select all that apply).
A. Diabetes Mellitus Type I
B. Diabetes Mellitus Type II
C. High Cholesterol
D. Sleep Apnea
E. Chronic Kidney Disease
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Appendix B

ID NO. ___________________
Blood Pressure Knowledge Scale© (revised)
In general, how likely do you believe that the following statements are true? Using the scale below, please
choose the number that best matches your answer.

Strongly
disagree

Strongly
Agree

1

Eating a low fat diet each day will help me
keep my blood pressure within normal
limits

1

2

3

4

5

6

7

2

Eating a low salt diet will help me keep my
blood pressure within normal limits

1

2

3

4

5

6

7

3

Eating a diet with at least five fruits and
vegetables each day will help me keep my
blood pressure within normal limits

1

2

3

4

5

6

7

4

Physical activity for at least 30 minutes
each day will help me keep my blood
pressure within normal limits

1

2

3

4

5

6

7

5

Seeing my doctor on a regular basis will
help me keep my blood pressure within
normal limits

1

2

3

4

5

6

7

6

If someone has high blood pressure the best
way to keep their blood pressure within
normal limits is by taking medicines every
day as prescribed by their doctor

1

2

3

4

5

6

7

7

Avoiding alcohol (such as beer, wine,
liquor) will help me keep my blood
pressure within normal limits

1

2

3

4

5

6

7

8

Reducing stress will help me keep my
blood pressure within normal limits

1

2

3

4

5

6

7

9

Maintaining normal body weight would
help me keep my blood pressure within
normal limits

1

2

3

4

5

6

7

Avoiding tobacco (such as smoking or
10 chewing) would help me keep my blood
pressure within normal limits

1

2

3

4

5

6

7

1

2

3

4

5

6

7

11

I will know if my blood pressure is high
(above normal limits) because of how I feel

© R.M. Peters
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Appendix C

ID NO. ___________________
Blood Pressure Self-Care Scale© (revised)
In general, how often are the following statements true about you? Using the scale below, please choose
the number that best matches your answer

Never
1

2

3

4

5

6

Always
7

1

I am eating a low-fat diet each day

1

2

3

4

5

6

7

2

I am eating a low-salt diet each day

1

2

3

4

5

6

7

3

I am eating a diet with at least five
fruits and vegetables each day

1

2

3

4

5

6

7

4

I am physically active at least 30
minutes each day

1

2

3

4

5

6

7

5

I am able to maintain a low level of
stress each day

1

2

3

4

5

6

7

6

I am able to maintain a healthy weight

1

2

3

4

5

6

7

7

I am drinking two or more alcoholic
drinks each day

1

2

3

4

5

6

7

8

I use tobacco

1

2

3

4

5

6

7

9

I see my doctor as often as he/she tells
me to.

1

2

3

4

5

6

7

10

I am taking my blood pressure pills
exactly as prescribed by my doctor
each day

1

2

3

4

5

6

7

© R.M. Peters
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